Liminal BioSciences

-$0.01 (-0.51%) Today

$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LMNL and other ETFs, options, and stocks.

About LMNL

Liminal BioSciences, Inc. is a biopharmaceutical corporation. The firm engages in the development of therapeutic products focusing on unmet medical needs in the field of fibrosis, autoimmune disease or inflammation and cancer.

CEO

Bruce Philip Pritchard

Employees

251

Headquarters

Laval, Québec

Founded

1994

LMNL Key Statistics

Market Cap

58.39M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

103.36K

High Today

$1.98

Low Today

$1.93

Open Price

$1.98

Volume

58.33K

52 Week High

$7.78

52 Week Low

$1.93

LMNL Earnings

-$1.25

-$0.83

-$0.42

$0.00

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Nov 11, After Hours

Why Robinhood?

Liminal BioSciences, Inc. is a biopharmaceutical corporation. The firm engages in the development of therapeutic products focusing on unmet medical needs in the field of fibrosis, autoimmune disease or inflammation and cancer. View more

Liminal BioSciences, Inc. is a biopharmaceutical corporation. The firm engages in the development of therapeutic products focusing on unmet medical needs in the field of fibrosis, autoimmune disease or inflammation and cancer.